Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $81.12 | $24.46 | 231.71% | 153.06x | 38.99x | 10.29x | 12.42x | 1.11x | $106.92M | 1.25% | $705.78M | 6.70 | $8.67B | 1,104.82 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $32.07 | $8.36 | 283.60% | 152.71x | 73.59x | 9.02x | 18.27x | 1.31x | $39.15M | 0.94% | $220.58M | 1.69 | $4.11B | 90.55 | ||
| KRYS | KRYSTAL BIOTECH INC | $332.29 | $76.74 | 332.99% | 40.18x | 44.70x | 22.28x | 7.24x | 2.64x | $257.78M | 2.63% | $1.36B | 46.03 | $9.42B | 40.36 | ||
| VCEL | VERICEL CORP | $40.26 | $8.13 | 395.00% | 83.88x | 71.43x | 6.71x | 5.57x | 2.06x | $61.66M | 3.00% | $370.04M | 7.25 | $2.03B | 46.06 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.51 | $19.70 | 197.03% | 153.97x | 24.69x | 3.32x | 1.79x | 0.98x | $738.18M | 6.52% | $6.32B | 32.68 | $14.64B | 37.95 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $92.24 | $16.09 | 473.35% | 64.50x | 78.09x | 7.62x | 10.20x | 2.96x | $197.20M | 2.73% | $710.19M | 9.08 | $7.17B | 47.19 | ||
| RPRX | ROYALTY PHARMA PLC | $67.18 | $37.05 | 81.32% | 35.73x | 12.38x | 11.79x | 3.95x | 0.71x | $2.92B | 9.78% | $9.79B | 21.99 | $46.78B | 39.78 | ||
| HALO | HALOZYME THERAPEUTICS INC | $130.91 | $71.97 | 81.90% | 36.77x | 14.52x | 9.23x | 103.51x | 0.71x | $806.22M | 5.25% | $143.54M | 1.22 | $16.84B | 23.44 | ||
| ADMA | ADMA BIOLOGICS INC | $11.41 | $7.09 | 60.82% | 15.85x | 14.34x | 5.08x | 6.26x | 0.92x | $116.47M | 4.47% | $408.21M | 1.79 | $2.62B | 11.23 | ||
| TGTX | TG THERAPEUTICS INC | $61.18 | $22.78 | 168.52% | 19.86x | 59.68x | 10.85x | 15.50x | 2.21x | $17.39M | 0.20% | $604.08M | 4.26 | $9.63B | 69.20 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.28 | $7.74 | 32.84% | 10.82x | 9.45x | 4.47x | 2.80x | 0.94x | $82.01M | 13.48% | $217.65M | 3.68 | $466.64M | 6.03 | ||
| INCY | INCYTE CORP | $120.39 | $54.04 | 122.80% | 57.60x | 38.03x | 4.07x | 4.35x | 0.82x | $684.87M | 2.80% | $5.64B | 27.76 | $21.29B | 23.74 | ||
| EXEL | EXELIXIS INC | $69.39 | $30.55 | 127.12% | 20.11x | 21.03x | 6.86x | 9.23x | 1.45x | $1.16B | 6.78% | $1.83B | 7.43 | $16.79B | 15.02 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $558.88 | $150.68 | 270.91% | 32.25x | 29.26x | 11.26x | 7.00x | 2.43x | $3.80B | 2.68% | $20.25B | 79.81 | $137.49B | 24.98 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $215.98 | $192.78 | 12.03% | 14.15x | 14.19x | 2.97x | 2.92x | 0.54x | $1.62B | 11.86% | $4.80B | 75.98 | $16.80B | 10.39 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $322.75 | $87.75 | 267.83% | 32.05x | 34.01x | 22.29x | 6.65x | 2.40x | $130.62M | 2.02% | $967.52M | 48.22 | $6.56B | 23.51 | ||
| TECH | BIO-TECHNE CORP | $72.66 | $16.59 | 338.09% | 62.10x | 34.97x | 9.33x | 5.40x | 1.97x | $263.22M | 2.32% | $2.11B | 13.52 | $11.42B | 32.84 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $927.89 | $435.56 | 113.04% | 22.12x | 15.51x | 6.14x | 3.01x | 1.17x | $3.76B | 3.94% | $31.71B | 308.48 | $95.78B | 16.66 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.76 | $31.54 | 22.89% | 12.34x | 9.31x | 2.34x | 2.26x | 0.69x | $354.90M | 15.80% | $999.24M | 17.25 | $1.86B | 6.65 | ||
| UTHR | UNITED THERAPEUTICS CORP | $598.72 | $210.58 | 184.32% | 19.80x | 22.10x | 8.09x | 4.01x | 2.63x | $1.09B | 4.29% | $6.40B | 150.24 | $23.88B | 14.24 | ||
| VCYT | VERACYTE INC | $50.01 | $11.90 | 320.23% | 34.73x | 25.78x | 7.12x | 2.90x | 2.93x | $165.99M | 4.15% | $1.39B | 17.36 | $3.76B | 26.91 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.06 | $1.41 | -24.89% | 7.57x | -2.39x | 1.31x | 1.40x | 0.42x | $19.58M | 31.89% | $44.20M | 0.76 | $13.00M | 1.70 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.